A Phase I Study of Tetrathiomolybdate (TM) in Combination With Carboplatin and Pemetrexed in Chemo-Naive Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer
Phase of Trial: Phase I
Latest Information Update: 28 Oct 2017
At a glance
- Drugs Tetrathiomolybdate (Primary) ; Carboplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 19 Oct 2017 Planned End Date changed from 1 Sep 2017 to 1 Oct 2018.
- 19 Oct 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Oct 2018.